GUANFACINE HYDROCHLORIDE — XIROMED, approved 2024-02-23 (ANDA218326).
3,120 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.